Cancer-derived lactic acid as a potential upstream contributor to tumor hypoxia.

Cancer-derived lactic acid may act as an upstream driver of tumor hypoxia, creating a self-reinforcing feedback loop that sustains hypoxic tumor regions.

• Why it matters: Understanding the mechanisms that maintain hypoxia is crucial because hypoxia promotes tumor progression, immune suppression, and resistance to therapy, yet its upstream contributors remain unclear.
• What they did: The authors review evidence suggesting that lactic acid produced by tumor cells under oxygenated conditions can influence tumor physiology, potentially initiating and maintaining hypoxia through metabolic and signaling pathways.
• The result: Targeting lactic acid production or transport could disrupt this feedback loop, offering new therapeutic strategies to mitigate hypoxia-driven tumor progression and resistance.